| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), SABS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.80M | - | - | |
| Pres | 3.00M | - | - | |
| Other | 2.40M | - | - | |
| COO | 1.80M | - | - | |
| Dir | 240.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2021 | Reich Samuel J | CEO And CFO | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% | |
| Jan 14, 2021 | Big Cypress Holdings LLC | CEO And CFO | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% | |
| Jan 14, 2021 | Katz Ilan | Director, 10% Owner | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% |